Showing results (621-630 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|August 5, 2025
Eplerenone Inhibits Atrial Autonomic Nerve Remodeling in Atrial Fibrillation Through ERK1/2 MAPK PathwayWei Xu, Cheng-Yuan Yu, Ding-Yu Wang, et al.Cardiovascular Therapeutics|April 10, 2013
Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartanNajah R Hadi, Nasser Ghaly Yousif, Mohammed S Abdulzahra, et al.Cardiovascular Therapeutics|May 8, 2013
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillationGerrit Frommeyer, Peter Milberg, Timo Uphaus, et al.Cardiovascular Therapeutics|February 13, 2013
A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalantEnrico Vizzardi, Francesca Salghetti, Ivano Bonadei, et al.Cardiovascular Therapeutics|March 14, 2013
Mulberry leaf diet protects against progression of experimental autoimmune myocarditis to dilated cardiomyopathy via modulation of oxidative stress and MAPK-mediated apoptosisSomasundaram Arumugam, Sayaka Mito, Rajarajan A Thandavarayan, et al.Cardiovascular Therapeutics|March 14, 2013
State of play of pharmacogenetics and personalized medicine in heart failureHelen M Parry, Alex S F Doney, Colin N A Palmer, et al.Cardiovascular Therapeutics|January 30, 2013
Deficiency of a new protein associated with cardiac syndrome X; called adropinAhmet Celik, Mehmet Balin, Mehmet Ali Kobat, et al.Cardiovascular Therapeutics|January 3, 2013
Anticoagulation in patients with dilated cardiomyopathy, low ejection fraction, and sinus rhythm: back to the drawing boardAlexandru Nicolae Mischie, Valentin Chioncel, Ionel Droc, et al.Cardiovascular Therapeutics|January 15, 2013
Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrelThomas Gremmel, Roza Badr Eslam, Renate Koppensteiner, et al.Cardiovascular Therapeutics|January 15, 2013
Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882Jasper Dingemanse, Laurent NicolasPageof 99